- The Official RhoGAM® Site – About RhoGAM® Brand
RhoGAM > Professional > About RhoGAM® Brand

About RhoGAM® Brand

RhoGAM® Brand was the first, and is still the leading1 prescribed Rho(D) immune globulin brand for the prevention of Rh hemolytic disease of the newborn (HDN). Prior to the introduction of RhoGAM® Brand in 1968, HDN was a major cause of infant mortality, responsible for an average of 10,000 deaths annually in the United States2. Since the introduction of Rh immune globulin products, like RhoGAM® Brand, the incidence of HDN has been virtually eliminated in most developed countries. RhoGAM® Brand is made by Ortho Clinical Diagnostics, a Johnson & Johnson company.

    1. In the U.S. (Data on File)
    2. Zimmerman DA.Rh: The Initmate History of a Disease and its Conquest. New York, NJ:  MacMilan Publishing Company. May 1973

RhoGAM® BRAND OFFERS ALL OF THESE BENEFITS:

  • A 40-year history of safety and reliability
    – No documented cases of viral transmission
    – No interruptions in product supply
  • A select pool of dedicated, carefully-screened plasma donors
  • Robust viral inactivation (including West Nile virus) and removal processes (including hepatitis A) to minimize risk of viral transmission
  • Dosing guidelines that align with ACOG and AABB standards
  • A product free of latex, preservatives, and human serum albumin
  • A comprehensive catalog of educational support materials

Hemolytic Disease of the Newborn

The Science Behind the Miracle

Heritage of Leadership